Recombinant HOXB13 Monoclonal Antibody

SKU: AN301916L

Size::50μL

Storage:Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.

Shipping:Ice bag

Exp date:12 months

Category ID_II:Primary Antibodies

Category ID_III:Monoclonal Antibodies;Recombinant Antibodies

Abbreviation:HOXB13

Target Synonym:HXB;Homeobox B;Homeo box B;Homeobox protein HoxB;Homeobox protein Hox B;Homeobox protein Hox-B;HOX B;HOXB13;PSGD;Homeo box B13;Homeobox B13;Homeobox protein Hox B13;Homeobox protein HoxB13;Homeobox protein Hox-B13;HOX B13;HOXB 13;HXB13;PSGD protein

Research Areas:Epigenetics and Nuclear Signaling;Cancer

Conjugation:Unconjugated

Host:Rabbit

Species reactivity:Human;

Application:WB

Isotype:IgG,κ

Clonality:Monoclonal;Recombinant

Clone NO.:A632

UNIProt ID:Q92826

Accession:

Background:HOXB13 is a member of the HOXB cluster which, along with the HOXA, HOXC, and HOXD clusters, governs embryonic patterning along the cranio-caudal axis. HOXB13 plays a key role in the development of the ventral prostate, where it is expressed highly from the embryonic stage through adulthood. Research studies have shown that both overexpression and RNA interference can inhibit the growth of prostate cancer cells. HOXB13 can function as a tumor suppressor by negatively regulating growth through repression of TCF4 and androgen receptor (AR) signaling. However, HOXB13 has also been shown to be overexpressed in more invasive prostate cancers, breast and ovarian cancers, and hepatocellular carcinomas. A common germline mutation G84E in the HOXB13 protein has recently been found to be associated with significant increased risk of prostate cancer. Currently, HOXB13 is being evaluated as a marker for metastatic lesions of prostate origin.

Concentration:1 mg/mL

Immunogen:Recombinant human HOXB13 fragment

Buffer:PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.

Purification method:Protein A purified

Dilution:WB 1:1000-1:5000

Calculated MW:31 kDa

ObservedMW:31 kDa